Liver Disease
From the Journals
Study supports routine rapid HCV testing for at-risk youth
Routine finger-stick testing was the most cost-effective way to screen urban adolescents and young adults for hepatitis C virus infection.
News from the FDA/CDC
To boost HCV testing in baby boomers, offer the option
Offer the test, and they’ll probably take it.
Feature
Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment
The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and...
From the Journals
VIDEO: Alcohol showed no cardiovascular benefits in nonalcoholic fatty liver disease
Long-term prospective studies are needed to better understand how types and doses of alcohol affect cardiovascular endpoints in patients with...
From the Journals
Biophysical properties of HCV evolve over course of infection
Density and infectivity in relation to lipoproteins can change with diet.
From the Journals
VA shares its best practices to achieve HCV ‘cascade of cure’
The VA “cascade of cure” for HCV has achieved sharp reductions in infection rates among veterans.
News
FDA warns of risks of excessive dosing of obeticholic acid
Liver function should be monitored at baseline and during treatment for safe dosing.
From the Journals
Statin use reduces death and decompensation in cirrhosis patients
More statins, more positive outcomes.
Latest News
Clinical trial: Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis
Family histories and samples from affected patients will be studied for a genetic factor in adult chronic cholestatic liver disease.
From the Journals
Study findings support uncapping MELD score
Uncapping the current Model for End-Stage Liver Disease (MELD) score may provide a better path toward making sure that patients most in need of a...